Counselors' Knowledge of the Adoption of Tobacco Cessation Medications in Substance Abuse Treatment Programs

被引:17
|
作者
Rothrauff, Tanja C. [1 ]
Eby, Lillian T. [1 ,2 ]
机构
[1] Univ Georgia, Inst Behav Res, Athens, GA 30602 USA
[2] Univ Georgia, Appl Psychol Program, Athens, GA 30602 USA
来源
AMERICAN JOURNAL ON ADDICTIONS | 2011年 / 20卷 / 01期
关键词
SMOKING-CESSATION; CIGARETTE-SMOKING; ADDICTIONS TREATMENT; ALCOHOL; DEPENDENCE; INTEGRATION; POPULATION; ATTITUDES; MORTALITY; SERVICES;
D O I
10.1111/j.1521-0391.2010.00095.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
This study assessed counselors' knowledge of the adoption of evidence-based tobacco cessation medications (TCMs)-varenicline, bupropion, and five nicotine replacement therapies (NRTs)-and predictors of adoption in diverse substance abuse treatment settings. We used Managing Effective Relationships in Treatment Services (MERITS I) data from 658 counselors working in 26 programs. Adoption of varenicline was reported by 16% of counselors, bupropion by 11%, and NRTs by 27%. Knowledge of the adoption of all types of TCMs was more likely to be reported by counselors who worked in treatment programs that adhered less to a 12-step orientation and restricted outdoor smoking for employees. Several additional unique predictors of varenicline and NRTs were identified. (Am J Addict 2010;00: 1-7).
引用
收藏
页码:56 / 62
页数:7
相关论文
共 50 条